We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

87 hedge funds and large institutions have $101M invested in Fortress Biotech in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

13% more funds holding

Funds holding: 77 → 87 (+10)

0.06% less ownership

Funds ownership: 2.33% → 2.27% (-0.06%)

13% less capital invested

Capital invested by funds: $117M → $101M (-$15.4M)

Holders
87
Holders Change
+10
Holders Change %
+12.99%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
30
Reduced
22
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.74M
2
NCM
Nantahala Capital Management
Connecticut
+$1.32M
3
BlackRock
BlackRock
New York
+$462K
4
AA
ALPS Advisors
Colorado
+$455K
5
SC
Sepio Capital
Utah
+$389K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$2.44M
2
PAM
Panagora Asset Management
Massachusetts
-$1.09M
3
Two Sigma Investments
Two Sigma Investments
New York
-$503K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$366K
5
LPL Financial
LPL Financial
California
-$321K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$27.5M +$1.32M +30,398 +6%
BlackRock
2
BlackRock
New York
$15M +$462K +10,677 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$14.5M +$3.74M +86,453 +40%
OM
4
Opaleye Management
Massachusetts
$12.3M +$166K +3,834 +2%
State Street
5
State Street
Massachusetts
$3.68M -$6.58K -152 -0.2%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$2.96M +$132K +3,054 +5%
Northern Trust
7
Northern Trust
Illinois
$2.36M +$97.1K +2,242 +5%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$2.23M +$866 +20 +0%
Millennium Management
9
Millennium Management
New York
$2.02M -$128K -2,966 -7%
SAM
10
Shikiar Asset Management
New York
$1.77M +$298K +6,883 +23%
Two Sigma Investments
11
Two Sigma Investments
New York
$1.76M -$503K -11,609 -24%
CL
12
CPWM LLC
Washington
$1.6M – – –
Two Sigma Advisers
13
Two Sigma Advisers
New York
$824K +$96.5K +2,227 +15%
N
14
Nuveen
North Carolina
$821K -$164K -3,791 -18%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$803K +$101K +2,329 +16%
6CM
16
683 Capital Management
New York
$635K – – –
KAS
17
Kestra Advisory Services
Texas
$618K +$22.2K +513 +4%
Charles Schwab
18
Charles Schwab
California
$540K +$28.6K +661 +6%
AA
19
ALPS Advisors
Colorado
$499K +$455K +10,505 New
JP Morgan Chase
20
JP Morgan Chase
New York
$497K +$307K +7,090 +211%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$488K -$127K -2,931 -22%
Wells Fargo
22
Wells Fargo
California
$483K +$53.4K +1,234 +14%
SC
23
Sepio Capital
Utah
$427K +$389K +8,983 New
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$405K -$7.8K -180 -2%
Goldman Sachs
25
Goldman Sachs
New York
$396K -$86.6K -1,999 -19%
1
2 3 4

FBIO Hedge Fund Activity: Q4 2020 in Review

87 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2020, worth a combined $101M — down 13% from $117M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FBIO positions and 9 closed out — a net gain of 10 holders — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $2.44M.

  • 87 institutional investors held Fortress Biotech (FBIO) as of Q4 2020, up from 77 in Q3 2020.
  • Funds reported $101M of Fortress Biotech stock for Q4 2020, down 13% quarter-over-quarter.
  • 19 funds opened new Fortress Biotech positions in Q4 2020 and 9 closed out, a net change of +10 holders.
  • The largest Fortress Biotech buyer in Q4 2020 was Vanguard Group, an estimated $3.74M added.
  • The largest Fortress Biotech seller in Q4 2020 was Morgan Stanley, an estimated $2.44M sold.

Based on aggregated 13F filings for Q4 2020.